Industrializing iPSC Feed Streams Via Critical Process Parameter And Raw Materials Optimization

Translating iPSC therapies from bench to clinic depends on upstream expansion processes that are consistent, schedulable, and GMP-ready. This poster presents a purpose-designed bioprocess that achieves 10,000-fold iPSC expansion in under two weeks using a weekend-free workflow, GMP-compatible raw materials, and a custom culture medium engineered for single-cell passaging. You will see how optimized parameters including media exchange volume, passage schedule, and dissociation contact time affect yield, viability, and quality attributes such as pluripotency, genomic stability, and trilineage differentiation potential.

Access the poster to evaluate whether this integrated approach fits your clinical manufacturing roadmap.